1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. USA: CDC, 2003. https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf . Accessed 28 Nov 2016.
2. World Health Organisation. Antimicrobial Resistance: Global report on surveillance. 2014. Geneva: WHO, 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/ . Accessed 28 Nov 2016.
3. Livermore DM, Woodford N. The beta lactamase threat in Enterobacteriaceae, pseudomonas and Acinetobacter. Trends in Microbiol. 2006;14(9):413–20. doi: 10.1016/j.tim.2006.07.008 .
4. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents. 2010;36(Suppl 3):S8–14. doi: 10.1016/S0924-8579(10)70004-2 .
5. World Health Organisation. Critically important antimicrobials for human medicine, 3rdedn. Geneva: WHO; 2011. http://apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf?ua=18&ua=1 . Accessed 28 Nov 2016.